AIMT
Aimmune Therapeutics, Inc.
Director Mark T Iwicki bought $300K of Aimmune Therapeutics, Inc.
Bought$300,000
$32.00Price
9,375Shares
+47%Stake
What AIMT did for a copier
Prices for AIMT after this filing aren't in yet.
Mark T Iwicki's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Feb 26. Filed Mon, Feb 26, 11:05 AM ET, during the session. Not investment advice.